Development of Dosimetry and Personalized Treatment in Radionuclide Therapy with Novel Nuclides
Project/Area Number |
18K07651
|
Research Category |
Grant-in-Aid for Scientific Research (C)
|
Allocation Type | Multi-year Fund |
Section | 一般 |
Review Section |
Basic Section 52040:Radiological sciences-related
|
Research Institution | Kindai University |
Principal Investigator |
|
Co-Investigator(Kenkyū-buntansha) |
若林 源一郎 近畿大学, 原子力研究所, 教授 (90311852)
|
Project Period (FY) |
2018-04-01 – 2022-03-31
|
Project Status |
Completed (Fiscal Year 2021)
|
Budget Amount *help |
¥4,030,000 (Direct Cost: ¥3,100,000、Indirect Cost: ¥930,000)
Fiscal Year 2020: ¥1,300,000 (Direct Cost: ¥1,000,000、Indirect Cost: ¥300,000)
Fiscal Year 2019: ¥1,300,000 (Direct Cost: ¥1,000,000、Indirect Cost: ¥300,000)
Fiscal Year 2018: ¥1,430,000 (Direct Cost: ¥1,100,000、Indirect Cost: ¥330,000)
|
Keywords | 核医学治療 / RI内用療法 / 線量評価 / アルファ核種 / ペプチド受容体放射性核種療法 / ベータ核種 / 個別化医療 / 標的アイソトープ治療 / アルファ線放出核種 / α核種 / β核種 |
Outline of Final Research Achievements |
The purpose of this study was to evaluate the absorbed dose in normal organs and lesions in Nuclear Medicine Therapy (Radionuclide Therapy) and to optimize the treatment method. Nuclear Medicine Therapy has made remarkable progress in both basic research and clinical application. Against this background, in this study, we introduced dose calculation software and established a patient dose calculation method in Nuclear Medicine Therapy based on biodistribution data. We also accumulated data on castration-resistant prostate cancer bone metastases treated with radium-223 and analyzed factors that lead to the development of personalized treatment. In the development of new Nuclear Medicine Therapy methods in the future, it is important to develop a method for acquiring biodistribution data and to construct a method for performing dose evaluation based on it.
|
Academic Significance and Societal Importance of the Research Achievements |
核医学治療(RI内用療法)が基礎研究としても臨床手法としても発展する中で、正常組織と腫瘍の線量評価の手法を開発し、線量評価を核医学治療の実施に役立てていくことは極めて重要である。実臨床において多数の核医学治療を行う本研究者らが、その中で線量評価に取り組み、その手法を開発して実際のデータを用いて検証した意義は大きい。
|
Report
(5 results)
Research Products
(54 results)
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
[Journal Article] Multicentre prospective observational study protocol for radiation exposure from gastrointestinal fluoroscopic procedures (REX-GI study)2020
Author(s)
Nishida T, Hayashi S, Takenaka M, Hosono M, Kogure H, Hasatani K, Yamaguchi S, Maruyama H, Doyama H, Ihara H, Yoshio T, Nagaike K, Yamada T, Yakushijin T, Takagi T, Tsumura H, Kurita A, Asai S, Ito Y, Kuwai T, Hori Y, Maetan I, Ikezawa K, Iwashita T, Matsumoto K, Inada M
-
Journal Title
BMJ Open
Volume: 10
Issue: 2
Pages: e033604-e033604
DOI
Related Report
Peer Reviewed / Open Access
-
[Journal Article] A randomized, double-blind, comparison of radium-223 and placebo, in combination with abiraterone acetate and prednisolone, in castration-resistant metastatic prostate cancer: subgroup analysis of Japanese patients in the ERA 223 study2020
Author(s)
Matsubara N, Kimura G, Uemura H, Uemura H, Nakamura M, Nagamori S, Mizokami A, Kikukawa H, Hosono M, Kinuya S, Krissel H, Siegel J, Yoshiyuki Kakehi Y
-
Journal Title
Int J Clin Oncol
Volume: 25
Issue: 4
Pages: 720-731
DOI
Related Report
Peer Reviewed
-
-
-
[Journal Article] ICRP Publication 140: Radiological Protection in Therapy with Radiopharmaceuticals2019
Author(s)
Yonekura Y, Mattsson S, Flux G, Bolch WE, Dauer LT, Fisher DR, Lassmann M, Palm S, Hosono M, Doruff M, Divgi C, Zanzonico P
-
Journal Title
Annals of the ICRP
Volume: 48
Issue: 1
Pages: 5-95
DOI
Related Report
Peer Reviewed / Open Access / Int'l Joint Research
-
-
[Journal Article] Evaluation and Optimization of a New PET Reconstruction Algorithm, Bayesian Penalized Likelihood Reconstruction, for Lung Cancer Assessment According to Lesion Size2019
Author(s)
Otani T, Hosono M, Kanagaki M, Oka S, Fukumoto G, Onishi Y, Matsubara N, Kawabata K, Kimura H
-
Journal Title
American Journal of Roentgenology
Volume: 213
Issue: 2
Pages: W50-W56
DOI
Related Report
Peer Reviewed
-
-
-
-
-
[Journal Article] Manual on the proper use of lutetium-177-labeled somatostatin analogue (Lu-177-DOTA-TATE) injectable in radionuclide therapy (2nd ed.)2018
Author(s)
Hosono M, Ikebuchi H, Nakamura Y, Nakamura N, Yamada T, Yanagida S, Kitaoka A, Kojima K, Sugano H, Kinuya S, Inoue T, Hatazawa J.
-
Journal Title
Ann Nucl Med
Volume: 32
Issue: 3
Pages: 217-235
DOI
Related Report
Peer Reviewed / Open Access
-
-
-
-
-
[Presentation] Previous pneumectomy is a risk factor of severe radiation pneumonitis after IMRT for lung cancer2021
Author(s)
Tatsuno S, Doi H, Okada W, noue E, Nakamura K, Sano K, Wada Y, Uehara T, Inada M, Nakamatsu K, Monzen K, Hosono M, Matsumoto K, Tanooka M, Tanaka M, Nishimura Y
Organizer
ESTRO 2021
Related Report
Int'l Joint Research
-
-
[Presentation] National survey and research on actual circumstances of radiation exposure and reduction of staff members working in nuclear medicine and other radiological procedures in Japan, Grant research of Ministry of Health, Labour and Welfare2020
Author(s)
Hosono M, Mikami Y, Watanabe H, Takenaka M, Koba Y, Kanda R, Akahane K, Torisu K, Sakamoto H, Yamamoto K
Organizer
Annual Congress of European Association of Nuclear Medicine
Related Report
Int'l Joint Research
-
[Presentation] National survey on actual conditions of radiation exposure and reduction for radiological staff members in Japan, Research group of Ministry of Health, Labour and Welfare2020
Author(s)
Hosono M, Mikami Y, Watanabe H, Takenaka M, Koba Y, Kanda R, Akahane K, Torisu K, Yamada T, Sakaguchi K, Sakamoto H, Yamamoto K
Organizer
Annual Meeting of Radiological Society of North America 2020
Related Report
Int'l Joint Research
-
-
-
-
-
-
-
-
[Presentation] Examination of actual radiation exposure dose of the patients who performed EUS-guided drainage (EUS-BD/EUS-PD/EUS-CD)2019
Author(s)
Takenaka M, Hayashi S, Nishida T, Hosono M, Yoshikawa T, Ishikawa Rei, Okamoto A, Yamazaki T, Nakai A, Omoto S, Minaga K, Kamata K, Yamao K, Kudo M
Organizer
DDW 2019
Related Report
Int'l Joint Research
-
-
-
-
-
-
-
-
-
-
-
-